1-13 of 13
Su Su
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical-Grade mRNA Electroporation of NK Cells: A Novel and Highly Efficient Method to Genetically Reprogram Human NK Cells for Cancer Immunotherapy

Mattias Carlsten, MD PhD, Linhong Li, Su Su, MD PhD, Maria Berg, Robert Reger, Madhusudan V. Peshwa, Richard Childs, MD
Journal: Blood
Blood (2014) 124 (21): 2153.
https://doi.org/10.1182/blood.V124.21.2153.2153
Published: 2014
Journal Articles

Discovery of Novel EPO/EPOR/JAK2 Targets and Signal Transduction Factors Via Proteomic-Based Interrogations of Post-Translational Motif Modifications

Don M Wojchowski, PhD, Su Su, PhD, Ashley Johnson, BA, Edward Jachimowicz, MS, Matthew P Stokes, PhD, Jennifer M Green, PhD, Jeffrey C Silva, PhD
Journal: Blood
Blood (2014) 124 (21): 1335.
https://doi.org/10.1182/blood.V124.21.1335.1335
Published: 2014
Journal Articles

Ligand-Regulated and Developmental Stage-Specific Expression Of The EPO Receptor During Human Erythroid Progenitor Cell Formation

Nicole Rainville, David Kuhrt, PhD, Su Su, PhD, Edward Jachimowicz, MS, Asch Ruth, Lei Li, MD PhD, Jennifer M Green, PhD, Don M. Wojchowski, PhD
Journal: Blood
Blood (2013) 122 (21): 3424.
https://doi.org/10.1182/blood.V122.21.3424.3424
Published: 2013
Journal Articles

Transcriptome- Based Analysis of EPO Dependent Cfu-e to Erythroblast Development

Rakesh Verma, Ph.D, Aishwarya Narayanan, PhD, David Kuhrt, PhD, Lei Li, PhD, Su Su, PhD, Ruth Asch, BA, Edward Jachimowicz, MS, Don M. Wojchowski, PhD
Journal: Blood
Blood (2012) 120 (21): 3188.
https://doi.org/10.1182/blood.V120.21.3188.3188
Published: 2012
Journal Articles

A Phase I Trial of Adoptively Transferred Ex-Vivo Expanded Autologous Natural Killer (NK) Cells Following Treatment with Bortezomib to Sensitize Tumors to NK Cell Cytotoxicity

Robert N Reger, Maria Berg, Andreas Lundqvist, PhD, Theresa Donohue, MHS, PA-C, Mattias Carlsten, MD Ph.D, Dawn M Betters, Ph.D, Lisa Cook, RN, BSN, Catalina Ramos, RN, BSN, Sophia Grasmeder, RN, BSN, OCN, Su Su, MD, PhD, David Stroncek, MD, Jeremy Pantin, MD, Keyvan Keyvanfar, BS, Cristian A. Carvallo, MD, Hahn Khuu, MD, Richard Childs, MD
Journal: Blood
Blood (2011) 118 (21): 1001.
https://doi.org/10.1182/blood.V118.21.1001.1001
Published: 2011
Journal Articles

Optimizing Lentiviral Transduction of Human Natural Killer Cells

Su Su, MD, PhD, Dawn M Betters, Ph.D, Muthalagu Ramanathan, MD, Keyvan Keyvanfar, BS, Aleah Smith, Xingmin Feng, PhD, Elissa Furutani, Mattias Carlsten, MD Ph.D, Andreas Lundqvist, PhD, Richard Childs, MD
Journal: Blood
Blood (2011) 118 (21): 4714.
https://doi.org/10.1182/blood.V118.21.4714.4714
Published: 2011
Journal Articles

Adoptive Transfer of Escalating Doses of Ex Vivo Expanded Autologous Natural Killer (NK) Cells In Patients with Advanced Malignancies Following Bortezomib Treatment to Sensitize to NK-TRAIL Cytotoxicity

Aleah Smith, Hahn Khuu, MD, Dawn M Betters, RN, Lisa Cook, RN, BSN, Catalina Ramos, RN, BSN, Sophia Grasmeder, RN, BSN, OCN, Maria Berg, Rebecca Lopez, PhD, Su Su, MD, PhD, Vicki Fellowes, MT, David Stroncek, MD, Jeremy Pantin, MD, Sumi Vasu, MD, Theresa Donohue, MHS, PA-C, Keyvan Keyvanfar, BS, Richard Childs, MD
Journal: Blood
Blood (2010) 116 (21): 4296.
https://doi.org/10.1182/blood.V116.21.4296.4296
Published: 2010
Journal Articles

siRNA Inactivation of the Inhibitory Receptor NKG2A Augments the Anti-Tumor Effects of Adoptively Transferred NK Cells In Tumor-Bearing Hosts

Elissa Furutani, Su Su, MD, PhD, Aleah Smith, Maria Berg, Richard Childs, MD
Journal: Blood
Blood (2010) 116 (21): 1015.
https://doi.org/10.1182/blood.V116.21.1015.1015
Published: 2010
Journal Articles

Toxic effects of sorafenib when given early after allogeneic hematopoietic stem cell transplantation

Hisayuki Yokoyama, Andreas Lundqvist, Su Su, Richard Childs
Journal: Blood
Blood (2010) 116 (15): 2858–2859.
https://doi.org/10.1182/blood-2010-06-291104
Published: 2010
Journal Articles

Lentiviral Transduction of Ex Vivo Expanded Natural Killer Cells with a CD19 Chimeric Antigen Receptor Induces Cytotoxicity against Resistant B Cell Malignancies

Muthalagu Ramanathan, Su Su, Andreas Lundqvist, Maria Berg, Aleah Smith, Rebecca Lopez, Ann Williams, Erkut Bahceci, J. Philip McCoy, Laurent Boissel, Hans-Georg Klingemann, Richard Childs
Journal: Blood
Blood (2008) 112 (11): 3540.
https://doi.org/10.1182/blood.V112.11.3540.3540
Published: 2008
Journal Articles

Adoptively-Infused NK Cells Maintain Their Antitumor Effects in Vivo in the Presence of CyclosporineA (CSA)

Hisayuki Yokoyama, Andreas Lundqvist, Maria Berg, Muthalagu Ramanathan, Rebecca Lopez, Aleah Smith, Nicole Gormley, Su Su, J. Phillip McCoy, Richard W. Childs, MD
Journal: Blood
Blood (2008) 112 (11): 2563.
https://doi.org/10.1182/blood.V112.11.2563.2563
Published: 2008
Journal Articles

Bortezomib Enhances the Antitumor Activity of Adoptively Infused Natural Killer Cells In Vivo: A Novel Approach To Override KIR-Mediated Inhibition of NK Cell Cytotoxicity.

Andreas Lundqvist, PhD, Sheila Rao, BS, Aleah Smith, BS, Maria Berg, BS, Su Su, PhD, Hisayuki Yokoyama, PhD, Shivani Srivastava, MD, Richard Childs, MD
Journal: Blood
Blood (2007) 110 (11): 1786.
https://doi.org/10.1182/blood.V110.11.1786.1786
Published: 2007
Journal Articles

The Proteasome Inhibitor Bortezomib Simultaneously Enhances NK Cell Tumor Cytotoxicity While Paradoxically Reducing Antigen Specific T-Cell Tumor Cytotoxicity.

Andreas Lundqvist, PhD, Sheila Rao, BS, Maria Berg, BS, Aleah Smith, BS, Su Su, PhD, Hisayuki Yokoyama, PhD, Shivani Srivastava, MD, Richard Childs, MD
Journal: Blood
Blood (2007) 110 (11): 1789.
https://doi.org/10.1182/blood.V110.11.1789.1789
Published: 2007